Research Archive — Page 51 of 134
-
November 3, 2022
Study explores possible drug target for neurological problems
A team at Case Western Reserve University and Vanderbilt University Medical Center has determined with atomic-level precision how two established drugs bind to and alter the conformation of a cell membrane transporter protein called NKCC1, shutting down its activity. -
November 3, 2022
Event to spotlight VUMC’s COVID-19 research efforts
The public is invited to listen in as scientists on the forefront of COVID-19 research at Vanderbilt University Medical Center share their personal stories on Wednesday afternoon, Nov. 16, in 214 Light Hall. -
October 28, 2022
VUMC mourns loss of noted hypertension expert Elijovich
Fernando Elijovich, MD, professor of Medicine in the Division of Clinical Pharmacology at Vanderbilt University Medical Center, died in Nashville on Oct. 21. He was 77. -
October 27, 2022
Translational Research Forum highlights range of studies
The 2022 Vanderbilt Translational Research Forum exemplified the range of studies conducted at Vanderbilt University Medical Center that are translating scientific discovery into clinical practice. -
October 27, 2022
Study reveals pathways for aggressive prostate cancer subtype
Research from Vanderbilt-Ingram Cancer Center has revealed new information about the molecular pathways of cribriform prostate cancer. -
October 27, 2022
Nominations for Vanderbilt Prize now being accepted
Nominations for the 2023 Vanderbilt Prize in Biomedical Science are now being accepted. The nomination deadline is Dec. 1. -
October 25, 2022
Vascular dysfunction during sepsis
Regulation of the enzyme Sirtuin 1 in blood vessel endothelial cells may drive altered metabolism and vascular dysfunction during sepsis, Vanderbilt researchers have discovered.